pathwayRes	pathway	pathwayTitle	GenesInPWs
<https://identifiers.org/wikipathways/WP106_r114258>	WP106	Alanine and aspartate metabolism	1
<https://identifiers.org/wikipathways/WP111_r117097>	WP111	Electron transport chain: OXPHOS system in mitochondria	8
<https://identifiers.org/wikipathways/WP117_r117743>	WP117	GPCRs, other	5
<https://identifiers.org/wikipathways/WP138_r122133>	WP138	Androgen receptor signaling pathway	2
<https://identifiers.org/wikipathways/WP1422_r118359>	WP1422	Sphingolipid pathway	1
<https://identifiers.org/wikipathways/WP15_r121694>	WP15	Selenium micronutrient network	4
<https://identifiers.org/wikipathways/WP1530_r118120>	WP1530	miRNA regulation of DNA damage response	1
<https://identifiers.org/wikipathways/WP183_r117060>	WP183	Proteasome degradation	1
<https://identifiers.org/wikipathways/WP185_r116785>	WP185	Integrin-mediated cell adhesion	1
<https://identifiers.org/wikipathways/WP186_r118416>	WP186	Homologous recombination	1
<https://identifiers.org/wikipathways/WP1971_r117762>	WP1971	Integrated cancer pathway	1
<https://identifiers.org/wikipathways/WP2203_r120724>	WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	1
<https://identifiers.org/wikipathways/WP2328_r120805>	WP2328	Allograft rejection	1
<https://identifiers.org/wikipathways/WP2332_r120725>	WP2332	Interleukin-11 signaling pathway	1
<https://identifiers.org/wikipathways/WP2355_r120664>	WP2355	Corticotropin-releasing hormone signaling pathway	1
<https://identifiers.org/wikipathways/WP2359_r119918>	WP2359	Parkin-ubiquitin proteasomal system pathway	1
<https://identifiers.org/wikipathways/WP2369_r118380>	WP2369	Histone modifications	2
<https://identifiers.org/wikipathways/WP2371_r119919>	WP2371	Parkinson's disease pathway	2
<https://identifiers.org/wikipathways/WP2380_r120727>	WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	1
<https://identifiers.org/wikipathways/WP24_r113974>	WP24	Peptide GPCRs	1
<https://identifiers.org/wikipathways/WP2431_r120812>	WP2431	Spinal cord injury	1
<https://identifiers.org/wikipathways/WP2446_r116593>	WP2446	Retinoblastoma gene in cancer	1
<https://identifiers.org/wikipathways/WP2516_r116808>	WP2516	ATM signaling pathway	1
<https://identifiers.org/wikipathways/WP2525_r116582>	WP2525	Trans-sulfuration and one-carbon metabolism	1
<https://identifiers.org/wikipathways/WP2533_r120261>	WP2533	Glycerophospholipid biosynthetic pathway	1
<https://identifiers.org/wikipathways/WP262_r116630>	WP262	Ebstein-Barr virus LMP1 signaling	1
<https://identifiers.org/wikipathways/WP2828_r119245>	WP2828	Bladder cancer	1
<https://identifiers.org/wikipathways/WP2840_r120866>	WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	1
<https://identifiers.org/wikipathways/WP286_r120663>	WP286	IL-3 signaling pathway	1
<https://identifiers.org/wikipathways/WP2864_r108133>	WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	1
<https://identifiers.org/wikipathways/WP2875_r117690>	WP2875	Constitutive androstane receptor pathway	1
<https://identifiers.org/wikipathways/WP2877_r119905>	WP2877	Vitamin D receptor pathway	3
<https://identifiers.org/wikipathways/WP2882_r120815>	WP2882	Nuclear receptors meta-pathway	1
<https://identifiers.org/wikipathways/WP289_r122789>	WP289	Myometrial relaxation and contraction pathways	1
<https://identifiers.org/wikipathways/WP2942_r119083>	WP2942	DDX1 as a regulatory component of the Drosha microprocessor	1
<https://identifiers.org/wikipathways/WP325_r116669>	WP325	Triacylglyceride synthesis	1
<https://identifiers.org/wikipathways/WP3287_r121705>	WP3287	Overview of nanoparticle effects	1
<https://identifiers.org/wikipathways/WP3300_r102277>	WP3300	Dual hijack model of Vif in HIV infection	1
<https://identifiers.org/wikipathways/WP334_r117741>	WP334	GPCRs, class B secretin-like	4
<https://identifiers.org/wikipathways/WP3594_r117682>	WP3594	Circadian rhythm genes	2
<https://identifiers.org/wikipathways/WP3613_r106539>	WP3613	Photodynamic therapy-induced unfolded protein response	1
<https://identifiers.org/wikipathways/WP3617_r106541>	WP3617	Photodynamic therapy-induced NF-kB survival signaling	1
<https://identifiers.org/wikipathways/WP3624_r122572>	WP3624	Lung fibrosis	3
<https://identifiers.org/wikipathways/WP3646_r116732>	WP3646	Hepatitis C and hepatocellular carcinoma	1
<https://identifiers.org/wikipathways/WP3668_r117756>	WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	1
<https://identifiers.org/wikipathways/WP382_r119087>	WP382	MAPK signaling pathway	1
<https://identifiers.org/wikipathways/WP3851_r121712>	WP3851	TLR4 signaling and tolerance	1
<https://identifiers.org/wikipathways/WP3865_r106524>	WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	3
<https://identifiers.org/wikipathways/WP3878_r117656>	WP3878	ATM signaling in development and disease 	2
<https://identifiers.org/wikipathways/WP3888_r116782>	WP3888	VEGFA-VEGFR2 signaling pathway	5
<https://identifiers.org/wikipathways/WP3915_r122574>	WP3915	Angiopoietin-like protein 8 regulatory pathway	1
<https://identifiers.org/wikipathways/WP3925_r117062>	WP3925	Amino acid metabolism	4
<https://identifiers.org/wikipathways/WP3929_r119247>	WP3929	Chemokine signaling pathway	1
<https://identifiers.org/wikipathways/WP3931_r117717>	WP3931	Embryonic stem cell pluripotency pathways	1
<https://identifiers.org/wikipathways/WP3940_r119248>	WP3940	One-carbon metabolism and related pathways	1
<https://identifiers.org/wikipathways/WP3959_r118468>	WP3959	DNA IR-double strand breaks and cellular response via ATM	1
<https://identifiers.org/wikipathways/WP399_r119242>	WP399	Wnt signaling pathway and pluripotency	1
<https://identifiers.org/wikipathways/WP4008_r117805>	WP4008	NO/cGMP/PKG mediated neuroprotection	2
<https://identifiers.org/wikipathways/WP4016_r120667>	WP4016	DNA IR-damage and cellular response via ATR	1
<https://identifiers.org/wikipathways/WP4172_r122580>	WP4172	PI3K-Akt signaling pathway	1
<https://identifiers.org/wikipathways/WP4204_r108297>	WP4204	Tumor suppressor activity of SMARCB1	1
<https://identifiers.org/wikipathways/WP4222_r107160>	WP4222	Phosphodiesterases in neuronal function	2
<https://identifiers.org/wikipathways/WP4223_r119284>	WP4223	Ras signaling	1
<https://identifiers.org/wikipathways/WP4224_r120400>	WP4224	Purine metabolism and related disorders	1
<https://identifiers.org/wikipathways/WP4241_r106520>	WP4241	Type 2 papillary renal cell carcinoma	1
<https://identifiers.org/wikipathways/WP4249_r117749>	WP4249	Hedgehog signaling pathway	1
<https://identifiers.org/wikipathways/WP4262_r108103>	WP4262	Breast cancer pathway	1
<https://identifiers.org/wikipathways/WP4288_r120407>	WP4288	MTHFR deficiency	1
<https://identifiers.org/wikipathways/WP4290_r118611>	WP4290	Metabolic reprogramming in colon cancer	1
<https://identifiers.org/wikipathways/WP4320_r116686>	WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	1
<https://identifiers.org/wikipathways/WP4324_r98172>	WP4324	Mitochondrial complex I assembly model OXPHOS system	2
<https://identifiers.org/wikipathways/WP4329_r101725>	WP4329	miRNAs involvement in the immune response in sepsis	1
<https://identifiers.org/wikipathways/WP4341_r122900>	WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	1
<https://identifiers.org/wikipathways/WP4352_r102218>	WP4352	Ciliary landscape	3
<https://identifiers.org/wikipathways/WP4396_r98945>	WP4396	Nonalcoholic fatty liver disease	1
<https://identifiers.org/wikipathways/WP4478_r121699>	WP4478	LTF danger signal response pathway	1
<https://identifiers.org/wikipathways/WP4481_r121702>	WP4481	Resistin as a regulator of inflammation	1
<https://identifiers.org/wikipathways/WP4493_r120800>	WP4493	Cells and molecules involved in local acute inflammatory response 	1
<https://identifiers.org/wikipathways/WP4507_r119314>	WP4507	Molybdenum cofactor (Moco) biosynthesis	1
<https://identifiers.org/wikipathways/WP4532_r103287>	WP4532	Intraflagellar transport proteins binding to dynein	1
<https://identifiers.org/wikipathways/WP4535_r109210>	WP4535	Envelope proteins and their potential roles in EDMD physiopathology	1
<https://identifiers.org/wikipathways/WP4536_r110928>	WP4536	Genes related to primary cilium development (based on CRISPR)	1
<https://identifiers.org/wikipathways/WP4541_r116745>	WP4541	Hippo-Merlin signaling dysregulation	1
<https://identifiers.org/wikipathways/WP4553_r103606>	WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	3
<https://identifiers.org/wikipathways/WP4630_r120771>	WP4630	Measles virus infection	2
<https://identifiers.org/wikipathways/WP465_r122957>	WP465	Tryptophan metabolism	1
<https://identifiers.org/wikipathways/WP4655_r105163>	WP4655	Cytosolic DNA-sensing pathway	2
<https://identifiers.org/wikipathways/WP4656_r120396>	WP4656	Joubert syndrome	1
<https://identifiers.org/wikipathways/WP4657_r120007>	WP4657	22q11.2 copy number variation syndrome	2
<https://identifiers.org/wikipathways/WP4659_r116555>	WP4659	Gastrin signaling pathway	1
<https://identifiers.org/wikipathways/WP4666_r119241>	WP4666	Hepatitis B infection	1
<https://identifiers.org/wikipathways/WP47_r120579>	WP47	Hedgehog signaling pathway	1
<https://identifiers.org/wikipathways/WP4705_r119081>	WP4705	Pathways of nucleic acid metabolism and innate immune sensing	2
<https://identifiers.org/wikipathways/WP4722_r117144>	WP4722	Glycerolipids and glycerophospholipids	1
<https://identifiers.org/wikipathways/WP4726_r120323>	WP4726	Sphingolipid metabolism: integrated pathway	1
<https://identifiers.org/wikipathways/WP4747_r116543>	WP4747	Netrin-UNC5B signaling pathway	3
<https://identifiers.org/wikipathways/WP4754_r115147>	WP4754	IL-18 signaling pathway	6
<https://identifiers.org/wikipathways/WP4758_r108284>	WP4758	Nephrotic syndrome	1
<https://identifiers.org/wikipathways/WP4786_r117852>	WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	2
<https://identifiers.org/wikipathways/WP4792_r119117>	WP4792	Purine metabolism	1
<https://identifiers.org/wikipathways/WP4803_r110008>	WP4803	Ciliopathies	1
<https://identifiers.org/wikipathways/WP4823_r119116>	WP4823	Genes controlling nephrogenesis	1
<https://identifiers.org/wikipathways/WP4860_r120599>	WP4860	Hijack of ubiquitination by SARS-CoV-2	1
<https://identifiers.org/wikipathways/WP4884_r120646>	WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	1
<https://identifiers.org/wikipathways/WP4891_r120510>	WP4891	COVID-19 adverse outcome pathway	1
<https://identifiers.org/wikipathways/WP4905_r115772>	WP4905	1q21.1 copy number variation syndrome	2
<https://identifiers.org/wikipathways/WP4906_r115773>	WP4906	3q29 copy number variation syndrome	2
<https://identifiers.org/wikipathways/WP4921_r116643>	WP4921	Mitochondrial complex III assembly	1
<https://identifiers.org/wikipathways/WP4928_r120795>	WP4928	MAPK pathway in congenital thyroid cancer	1
<https://identifiers.org/wikipathways/WP4932_r118797>	WP4932	7q11.23 copy number variation syndrome	5
<https://identifiers.org/wikipathways/WP4946_r117703>	WP4946	DNA repair pathways, full network	2
<https://identifiers.org/wikipathways/WP4961_r120610>	WP4961	STING pathway in Kawasaki-like disease and COVID-19	2
<https://identifiers.org/wikipathways/WP4963_r122690>	WP4963	p53 transcriptional gene network	1
<https://identifiers.org/wikipathways/WP497_r119105>	WP497	Urea cycle and metabolism of amino groups	1
<https://identifiers.org/wikipathways/WP500_r121748>	WP500	Glycogen synthesis and degradation	1
<https://identifiers.org/wikipathways/WP5036_r119016>	WP5036	Angiotensin II receptor type 1 pathway	2
<https://identifiers.org/wikipathways/WP5037_r120417>	WP5037	Riboflavin and CoQ disorders	1
<https://identifiers.org/wikipathways/WP5038_r121595>	WP5038	Mitochondrial immune response to SARS-CoV-2	2
<https://identifiers.org/wikipathways/WP5039_r120358>	WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	1
<https://identifiers.org/wikipathways/WP5055_r122621>	WP5055	Burn wound healing	1
<https://identifiers.org/wikipathways/WP5087_r122659>	WP5087	Malignant pleural mesothelioma	1
<https://identifiers.org/wikipathways/WP5088_r119639>	WP5088	Prostaglandin signaling	1
<https://identifiers.org/wikipathways/WP5095_r120801>	WP5095	Overview of proinflammatory and profibrotic mediators	1
<https://identifiers.org/wikipathways/WP5101_r119172>	WP5101	Congenital generalized lipodystrophy (CGL)	1
<https://identifiers.org/wikipathways/WP5113_r119486>	WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	3
<https://identifiers.org/wikipathways/WP5114_r119169>	WP5114	Nucleotide excision repair in xeroderma pigmentosum 	1
<https://identifiers.org/wikipathways/WP5115_r120811>	WP5115	Network map of SARS-CoV-2 signaling pathway	1
<https://identifiers.org/wikipathways/WP5117_r119395>	WP5117	Cohesin complex - Cornelia de Lange syndrome	3
<https://identifiers.org/wikipathways/WP5118_r119397>	WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	1
<https://identifiers.org/wikipathways/WP5143_r120629>	WP5143	GDNF signaling	1
<https://identifiers.org/wikipathways/WP5144_r120537>	WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	1
<https://identifiers.org/wikipathways/WP5178_r122450>	WP5178	Disorders of fructose metabolism	1
<https://identifiers.org/wikipathways/WP5183_r122816>	WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	1
<https://identifiers.org/wikipathways/WP5199_r122599>	WP5199	PtdIns(4,5)P2 in cytokinesis pathway	1
<https://identifiers.org/wikipathways/WP5221_r122738>	WP5221	2q11.2 copy number variation syndrome	1
<https://identifiers.org/wikipathways/WP5222_r122737>	WP5222	2q13 copy number variation syndrome	1
<https://identifiers.org/wikipathways/WP5224_r122740>	WP5224	2q37 copy number variation syndrome	4
<https://identifiers.org/wikipathways/WP534_r117147>	WP534	Glycolysis and gluconeogenesis	1
<https://identifiers.org/wikipathways/WP585_r107188>	WP585	Interferon type I signaling pathways	1
<https://identifiers.org/wikipathways/WP623_r107189>	WP623	Oxidative phosphorylation	7
<https://identifiers.org/wikipathways/WP706_r117178>	WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	2
<https://identifiers.org/wikipathways/WP707_r116541>	WP707	DNA damage response	1
<https://identifiers.org/wikipathways/WP710_r116542>	WP710	DNA damage response (only ATM dependent)	1
<https://identifiers.org/wikipathways/WP727_r116775>	WP727	Monoamine transport	1
<https://identifiers.org/wikipathways/WP75_r119233>	WP75	Toll-like receptor signaling pathway	1
